Featured
Status
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment40 See more
- Anthropology, Education, Sociology and Social Phenomena4 See more
-
Chemicals and Drugs400
- Amino Acids, Peptides, and Proteins 103
- Biological Factors 25
- Biomedical and Dental Materials 1
- Carbohydrates 16
- Chemical Actions and Uses 63
- Complex Mixtures 32
- Enzymes and Coenzymes 11
- Heterocyclic Compounds 130
- Hormones, Hormone Substitutes, and Hormone Antagonists 31
- Inorganic Chemicals 47
- Lipids 12
- Macromolecular Substances 2
- Nucleic Acids, Nucleotides, and Nucleosides 24
- Organic Chemicals 202
- Pharmaceutical Preparations 10
- Polycyclic Compounds 62
-
Diseases887
- Animal Diseases 1
- Bacterial Infections and Mycoses 65
- Cardiovascular Diseases 92
- Chemically-Induced Disorders 38
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 125
- Digestive System Diseases 89
- Endocrine System Diseases 73
- Eye Diseases 16
- Female Urogenital Diseases and Pregnancy Complications 95
- Hemic and Lymphatic Diseases 117
- Immune System Diseases 126
- Male Urogenital Diseases 78
- Musculoskeletal Diseases 43
- Neoplasms 215
- Nervous System Diseases 147
- Nutritional and Metabolic Diseases 121
- Occupational Diseases 4
- Otorhinolaryngologic Diseases 20
- Parasitic Diseases 13
- Pathological Conditions, Signs and Symptoms 294
- Respiratory Tract Diseases 45
- Skin and Connective Tissue Diseases 40
- Stomatognathic Diseases 17
- Virus Diseases 68
- Wounds and Injuries 30
- Health Care7 See more
-
Phenomena and Processes58
- Psychiatry and Psychology133 See more
- Technology, Industry, Agriculture7 See more
Search Clinical Trials
Completed
A Trial of Levodopa in Angelman Syndrome (External Link)
Levodopa is a prodrug that "delivers" dopamine to the brain. It is usually given with carbidopa, a peripheral decarboxylase inhibitor, to increase the bioavailability of levodopa. Animal studies have suggested …
Baylor Role:
Collaborator
Completed
Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) (External Link)
Blood has been previously taken from the patient and the donor to make the cells. To make the special cell line, special blood cells called dendritic cells (DCs)were made first …
Baylor Role:
Lead Sponsor
Completed
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome (External Link)
Many children experience stomach pain or discomfort at some point during their lives. Some children have belly discomfort frequently while others rarely have this problem. There have been very few …
Baylor Role:
Lead Sponsor
Completed
Healthy Eating and Lifestyle for Total Health (External Link)
The goal of the research was to examine the association between weight and the barriers and facilitators to meeting the DGA in a multi-site study using a cross-sectional survey. 836 …
Baylor Role:
Lead Sponsor
Completed
Varenicline as a Treatment for Methamphetamine Dependence (External Link)
This study is part of an effort to develop treatments for methamphetamine abuse. Varenicline is a drug that changes levels of certain brain chemicals that may also be useful in …
Baylor Role:
Lead Sponsor
Completed
Evaluation of Computer Generated After Visit Summaries (External Link)
We will conduct an experiment in the four selected primary care clinics to test objectively the effect of three levels of AVS content on patient recall of personal visit information, …
Baylor Role:
Lead Sponsor
Completed
Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals (External Link)
HIV-1 infection ultimately results in impaired specific immune function by virtue of the initial binding of the HIV-1 virion envelope glycoprotein 120 (gp120) to the CD4 receptor in complex with …
Baylor Role:
Lead Sponsor
Terminated
Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme (External Link)
To generate CMV-T cells we put a specially produced carrier virus (adenovirus) that carries one CMV gene into the patient's blood monocytes or dendritic cells. These cells are then used …
Baylor Role:
Lead Sponsor
Withdrawn
Umbilical Cord Blood Transplant for Children With Lymphoid Hematological Malignancies (External Link)
After the eligible criterion for treatment has been met and a suitable UCB stem donor has been found, the patient will have a central line placed. Research Therapy: After placement …
Baylor Role:
Lead Sponsor
Completed
Umbilical Cord Blood Transplant for Children With Myeloid Hematological Malignancies (External Link)
The following will be given as the conditioning regimen for the transplant: BUSULFAN: Busulfan (intravenous BUSULFEX) dosing will be as follows: patients <12 kg: 1.1 mg/kg/dose IV every 6 hours …
Baylor Role:
Lead Sponsor